Swine Mycoplasma Vaccine Market, Global Outlook and Forecast 2024-2030 || Download FREE Sample of this Report https://lnkd.in/dYqgDZ-C
The global Swine Mycoplasma Vaccine market was valued at US$ 665.7 million in 2023 and is projected to reach US$ 1101.9 million by 2030, at a CAGR of 7.5% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
key players include:
Zoetis
Boehringer Ingelheim
Jinhe Biotechnology Co., Ltd.
Merck Group
HIPRA
Harbin Pharmaceutical Group Co., Ltd.
Pulike Biological Engineering,Inc
Qilu Animal Health Products Co., Ltd.
Wuhan KEQIAN Animal Health care biologicals Co., ltd. Biology
Guangdong Winsun Bio-Pharmaceutical
Get the Complete Report & TOC https://lnkd.in/dVnP_Edv
CONTACT US:
276 5th Avenue, New York , NY 10001,United States
International: (+1) 332 2424 294 / +91 8087042414
Follow Us On linkedin :- https://lnkd.in/d-gZVjNy
#swinemycoplasmavaccine #vaccine #biotechnology #pharma #pharmaceutical #swinemycoplasmavaccinemarketreport #swinemycoplasmavaccinemarketsize #swinemycoplasmavaccinemarketshare #grandresearchstore
